A previous study showed that the level of IgM antibodies against phosphorylcholine (IgM anti-PC) was negatively associated with the atherosclerotic disease burden in patients in the acute phase of ST-elevation myocardial infarction (STEMI) (Knudsen et al., 2019). Here, CD40LG is linked to ST Elevation Myocardial Infarction.